BIOMERICA INC
BMRANasdaq
$1.61
↓ -1.0%Jul 17 close · end-of-day
Price
1Y↓ -48.8%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$4.9M
Enterprise Value
$3.5M
P/E
—
P/S
1.1
P/B
1.5
EV/EBITDA
—
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
$4.3M
Net Income (TTM)
-$4.2M
Free Cash Flow (TTM)
—
Gross Margin
4.3%
Operating Margin
-123.8%
Net Margin
-96.5%
ROE
-125.8%
ROIC
-213.5%
Debt / Equity
—
Net Cash
$1.3M
Return 1Y
-52.5%
Company profile
Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications. It primarily sells its products for gastrointestinal diseases, food intolerances, diabetes, and various esoteric tests.
- CEO
- Zackary S. Irani
- Sector
- Manufacturing
- Industry
- Pharmaceutical Products
- Employees
- 60
- Headquarters
- California
- Website
- biomerica.com
Management & directors
- Barbieri AllenExecutive Vice-Chairman
- Irani Zackary S.Chief Executive Officer
- Lu GaryChief Financial Officer
Roles derived from SEC Form 4 filings.
Earnings
BMRA Q3 2026 Earnings
Period ends 2026-02-28
MetricActualYoY
Revenue$987,000.00↓ -11.8%
Diluted EPS-$0.44↓ -8.3%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $7.2M | $18.9M | $5.3M | $5.4M | $5.3M |
| Gross profit | $366,285.00 | $3.0M | $446,000.00 | $611,000.00 | $498,000.00 |
| Operating income | -$7.5M | -$4.5M | -$7.2M | -$6.4M | -$5.1M |
| Net income | -$7.4M | -$4.5M | -$7.1M | -$6.0M | -$5.0M |
| Diluted EPS | -$0.62 | -$0.36 | -$0.50 | -$2.84 | -$2.16 |
| Operating cash flow | -$5.3M | -$479,000.00 | -$5.5M | -$5.4M | -$3.8M |
| Free cash flow | -$5.4M | -$536,000.00 | -$5.5M | -$5.4M | — |
| Gross margin | 5.1% | 15.8% | 8.4% | 11.3% | 9.4% |
| Operating margin | -104.2% | -24.0% | -135.3% | -117.6% | -96.7% |
| Net margin | -103.4% | -24.0% | -133.7% | -110.4% | -93.6% |
| Line item | Q4 '24 | Q1 '24 | Q2 '24 | Q3 '25 | Q4 '25 | Q1 '25 | Q2 '25 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.1M | $1.8M | $1.6M | $1.1M | $749,000.00 | $1.4M | $1.2M | $987,000.00 |
| Gross profit | $23,000.00 | $289,000.00 | $437,000.00 | $19,000.00 | -$247,000.00 | $424,000.00 | $51,000.00 | -$44,000.00 |
| Operating income | -$1.5M | -$1.4M | -$993,000.00 | -$1.2M | -$1.6M | -$1.1M | -$1.4M | -$1.3M |
| Net income | -$1.4M | -$1.3M | -$950,000.00 | -$1.2M | -$1.5M | $2,000.00 | -$1.3M | -$1.3M |
| Diluted EPS | -$2.57 | -$0.63 | -$0.06 | -$0.48 | -$0.99 | $0.00 | -$0.45 | -$0.44 |
| Operating cash flow | -$1.0M | -$1.3M | -$791,000.00 | -$1.0M | -$661,000.00 | -$268,000.00 | -$991,000.00 | -$1.3M |
| Free cash flow | -$1.1M | — | — | — | — | — | — | — |
| Gross margin | 2.1% | 16.0% | 26.7% | 1.7% | -33.0% | 30.7% | 4.2% | -4.5% |
| Operating margin | -136.6% | -75.7% | -60.7% | -108.1% | -209.1% | -81.0% | -113.5% | -131.5% |
| Net margin | -127.1% | -72.8% | -58.1% | -103.9% | -206.1% | 0.1% | -109.1% | -132.9% |
Company news
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
No insider transactions in the last 12 months.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2025-12-12 | Chin Eric | Award | 22,500 | $0.00 | $0.00 | filing |
| 2025-12-12 | Lu Gary· Chief Financial Officer | Award | 40,000 | $0.00 | $0.00 | filing |
| 2025-12-12 | Irani Zackary S.· Chief Executive Officer | Award | 52,500 | $0.00 | $0.00 | filing |
| 2025-12-12 | BARBIERI ALLEN· Executive Vice-Chairman | Award | 30,000 | $0.00 | $0.00 | filing |
| 2025-12-12 | MOATAZEDI DAVID | Award | 20,000 | $0.00 | $0.00 | filing |
| 2025-12-12 | Gary M. Huff | Award | 20,000 | $0.00 | $0.00 | filing |
Latest 6 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.